Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
AJNR Am J Neuroradiol ; 32(4): 709-13, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21349956

RESUMEN

BACKGROUND AND PURPOSE: dVRS have been previously associated with aging and cerebrovascular diseases. However, little is known about their prevalence and topographic distribution in the general elderly population. MATERIALS AND METHODS: dVRS were evaluated by using high-resolution 3D MR imaging in 1826 subjects enrolled in the 3C-Dijon MR imaging study. On T1-weighted MR imaging, dVRS were detected according to 3D imaging criteria and rated by using 4-level severity scores based in the BG or in the WM. The number and anatomic location of large dVRS (≥3 mm) were recorded. RESULTS: dVRS were observed in the BG or WM in every subject. The severity of dVRS was significantly associated with higher age in both the BG and WM, whereas sex was related to the severity of dVRS only in the BG. Large dVRS were detected in 33.2% of participants. Status cribrosum was found in 1.3% of participants. dVRS were also highly prevalent within the hippocampus (44.5%) and hypothalamus (11.6%). CONCLUSIONS: dVRS are always detected in the BG or WM in elderly people, and large dVRS are also prevalent. The topographic distribution of dVRS is not uniform within the brain and may depend on anatomic or pathologic characteristics interacting with aging and sex.


Asunto(s)
Envejecimiento/patología , Enfermedad Cerebrovascular de los Ganglios Basales/patología , Imagenología Tridimensional , Leucoencefalopatías/patología , Imagen por Resonancia Magnética/métodos , Anciano , Ganglios Basales/patología , Enfermedad Cerebrovascular de los Ganglios Basales/epidemiología , Femenino , Hipocampo/patología , Humanos , Hipotálamo/patología , Leucoencefalopatías/epidemiología , Imagen por Resonancia Magnética/normas , Masculino , Prevalencia , Valores de Referencia , Factores de Riesgo , Índice de Severidad de la Enfermedad
2.
J Perinatol ; 26(1): 57-63, 2006 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-16319938

RESUMEN

High-dosage, tocolytic magnesium sulfate (MgSO4) administered to pregnant women during preterm labor can be toxic, and sometimes lethal, for their newborns (Cochrane Database of Systematic Reviews (relative mortality risk 2.82, 95% confidence interval 1.2-6.6)). Based on the results of the Magnesium and Neurologic Endpoints Trial and the work of many others, a unifying triangular concept is proposed to account for the increased prevalence of brain lesions, with their likely resultant mortality, in neonates and infants exposed to high-dose MgSO4 in the context of preterm labor. We review the evidence that: (1) elevated circulating levels of serum ionized magnesium occurring in mothers, and therefore in their babies, at the time of delivery are associated with subsequent neonatal intraventricular hemorrhage (IVH); (2) neonatal IVH is strongly associated with lenticulostriate vasculopathy (LSV), an unusual mineralizing lesion involving the thalami and basal ganglia of the neonate; and, (3) exposure to 50 g or more of tocolytic MgSO4 during preterm labor is associated with the development of LSV.


Asunto(s)
Enfermedad Cerebrovascular de los Ganglios Basales/inducido químicamente , Hemorragia Cerebral/inducido químicamente , Sulfato de Magnesio/efectos adversos , Efectos Tardíos de la Exposición Prenatal , Tocolíticos/efectos adversos , Enfermedad Cerebrovascular de los Ganglios Basales/epidemiología , Hemorragia Cerebral/epidemiología , Parálisis Cerebral/prevención & control , Femenino , Humanos , Recién Nacido , Sulfato de Magnesio/sangre , Sulfato de Magnesio/uso terapéutico , Trabajo de Parto Prematuro/tratamiento farmacológico , Trabajo de Parto Prematuro/prevención & control , Embarazo , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Efectos Tardíos de la Exposición Prenatal/epidemiología , Ensayos Clínicos Controlados Aleatorios como Asunto/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto/mortalidad , Tocolíticos/sangre , Tocolíticos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA